Scaling Bio 008: Serif Biomedicines' Jake Rubens on Turning Modified DNA Into a New Class of Medicine
In this episode, Jake Rubens of Serif Biomedicines explains how the company is turning DNA into a new class of medicines by using chemically modified DNA and a protein co‑factor to overcome DNA’s historic immunogenicity and delivery challenges. He contrasts DNA therapeutics with mRNA and viral gene therapies, highlighting DNA’s potential for longer half‑life, redosability, and cell‑specific expression while remaining scalable. Rubens outlines the platform’s workflow—lipid nanoparticle delivery, nuclear entry, demodification, and transient epizomal expression—and shares early preclinical data showing safe, durable protein production in animal models. The discussion also touches on target selection criteria and future programs in liver disease and immune‑cell engineering.
Exclusive: Michigan US Senate Candidate Dr. Abdul El-Sayed on Healthcare, Trump and More
In this episode, Michigan Democratic Senate candidate Dr. Abdul El‑Sayed, a physician‑epidemiologist, discusses his push for universal, single‑payer health care, emphasizing that the system’s cost is a major burden for Americans and that corporate money has corrupted Democratic messaging. He...
Dayton Children’s Whitlock Says TEFCA Trust Model Needs Stronger Guardrails to Stop Data Misuse
In this episode, Dayton Children’s CIO J.D. Whitlock discusses the challenges of TEFCA’s trust model, highlighting how inadequate guardrails have allowed patient data to be misused for non‑clinical purposes, exemplified by the Health Gorilla lawsuit. He explains the complex governance...
Black Doulas, Maternal Health, and the Erasure We've Never Talked About
The episode explores the centuries‑old role of Black doulas and midwives—tracing their roots to West African traditions and their dominance in U.S. births from the 1600s through the early 20th century. It explains how the medicalization of childbirth shifted care...
Keto Saved My Life — The Future of Metabolic Medicine | Nick Norwitz PhD MD
In this episode, Dr. Nick Norwitz, a PhD in human metabolism and new Harvard MD, shares how a ketogenic diet rescued him from severe ulcerative colitis, leading to complete remission and allowing him to finish his PhD and medical training....
UNC Health’s Moosavi Says Analytics Teams Must Deeply Understand Requests Before Moving Forward; No Place for Ticket-Taking
In this episode, UNC Health’s Chief Analytics Officer Rachani Moosavi discusses how analytics teams must deeply understand stakeholder needs before building solutions, emphasizing that analytics is not a ticket‑taking function. She shares her diverse background—from nursing aide to patient‑flow consulting...
Medical Doctor Shares Life Changing Ibogaine Treatment Stories
In this episode, Dr. Fernando Vega, a family physician with 45+ years of practice, discusses his extensive work using psychedelic medicines—especially ibogaine—to treat PTSD, depression, anxiety, and opioid addiction. He shares compelling case stories, including a former alcoholic who regained...
Declaring Health Sovereignty
The episode examines the fallout from the United States’ withdrawal from the World Health Organization (WHO) and the broader implications for global health governance. Host James Corbett critiques the WHO’s pandemic response, highlights emerging threats like avian influenza, and explores...
Transforming the U.S. Department of Veterans Affairs: A Conversation with Deputy Secretary Dr. Paul Lawrence
In this hour-long interview, Deputy Secretary Dr. Paul Lawrence outlines his role as the VA’s chief operating officer and shares the department’s strategic vision to deliver world‑class health care, benefits, and memorial services to veterans. He highlights three urgent priorities:...
Major Antineoplastic Mechanisms of Combination Ivermectin-Mebendazole
In this episode of American Sunrise, chief scientific officer Dr. Peter McCullough discusses a new wellness‑company study showing that the antiparasitic drugs ivermectin and mebendazole, when used alongside standard cancer therapies, yielded an 84% positive net clinical benefit in over 200...
The Real Drivers of GLP-1 Growth
In this episode, Terrence Flynn, Morgan Stanley’s Head of U.S. Pharma and Biotech Research, outlines the next phase of growth for GLP‑1 obesity medicines, estimating the market could peak at about $190 billion globally. He highlights five key drivers: the shift...
Can AI Help Us Finally Beat Cancer W/ Dr. Sanjay Juneja, TheOncDoc
In this episode of CareTalk, oncologist Dr. Sanjay Ganesha (TheOncDoc) discusses how advances in AI, immunotherapy, CAR‑T, and early‑detection blood tests are turning cancer from a death sentence into a manageable disease. He shares his personal journey from a vision‑loss...
![[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://megaphone.imgix.net/podcasts/d0db1eda-2c6f-11ef-958d-9fb4aba9c1ce/image/0bfc12f76c8a92fdb53253e1c884033d.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress)
[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight
In this episode of Lifers, host Christina Farr talks with Sunita Mohanty, CEO and co‑founder of Ultralight, about the booming interest in peptide therapies for wellness and longevity. Sunita explains that while peptides are gaining popularity—driven by anecdotal success, recent...
Live From TAHFM 2026: Facility Leaders & Conference Highlights
The episode recaps the Texas Association of Healthcare Facilities Managers (TAHFM) 2026 conference, highlighting the industry’s triple aging crisis—workforce, buildings, and infrastructure—and how the Healthcare Facilities Network is addressing it. Guests, including facility leaders Jim, David Trask, Joe Stockman, and...
Ep. 4 - Cost-Plus Pricing: What Plan Sponsors Should Know
In this episode of Benefits Bites, hosts Madison and Mike unpack cost‑plus pricing, a model gaining traction through entities like Mark Cuban’s Cost Plus Drug Company and state legislation mandating reimbursements based on NADAC plus a dispensing fee. They explain...
Rebuild, Don’t Just Relieve Pain: The Peptide Revolution for Lasting Joint Health
In this episode, host Steve discusses chronic inflammation and joint pain with Dr. Peter McCullough, chief scientific officer of a wellness company. Dr. McCullough explains how traditional pain relievers only mask symptoms, while their peptide‑based products—Regenerate (oral drops) and Therablu (topical...
The 5 Top Health Lies & The Truth You Need to Feel Better Today
In this episode, Mel Robbins sits down with Dr. Mike Varshavsky, the most‑followed practicing physician online, to expose the five biggest health myths circulating on the internet and reveal the evidence‑based truths that can improve daily wellbeing. Dr. Mike explains...
Childhood Vaccine Schedule: Court Ruling Raises Questions About Who Decides
The episode examines a recent federal court ruling that upheld the American Academy of Pediatrics' (AAP) authority over the childhood vaccine schedule, blocking attempts to scale it back. Guest Dr. Ryan Cole, head of medical and scientific affairs at the Independent...
My Recent Interview on RCR with Paul Brennan – Exposing the Machinery Behind the COVID Response and What's Coming Next
In this episode of RCR with Paul Brennan, investigative journalist Sonia Elijah discusses her new book, *3.11: Viral Takeover*, which offers a forensic timeline of the COVID‑19 response and the emergence of a global biodefense industrial complex. She highlights how...
Anthropic's IPO Play, Novo Nordisk X OpenAI, and the First Brain Sensor Goes Human
The episode covers a rapid round‑up of AI‑related headlines: Apple is testing four frame designs for smart glasses that will focus on camera, call, and AI assistant functions rather than AR; Vercel’s CEO announced a surge to a $340 million ARR...
Why Genetic Diagnoses Take So Long for Kids
In this brief episode, host Catherine interviews the CEO of GeneDX about the stark delay—averaging five years—in diagnosing children with genetic diseases, despite the availability of rapid whole exome and genome sequencing that can deliver results in days. She explains...
The Spike, The Silence, and the System
In this episode, host Grant Stinchfield and Dr. Peter McCullough discuss a controversial CDC chart that appears to show a spike in U.S. deaths coinciding with the rollout of COVID‑19 vaccines in 2021, arguing the pattern suggests vaccine‑related mortality. They critique...
DDW Highlights: 14 April 2026
In this episode, Bruno Quinney highlights three major developments: the discovery of a new recessive neurodevelopmental disorder linked to mutations in the non‑coding gene RNU4‑2, a first‑in‑human trial of personalized CAR‑T cell therapies for hard‑to‑treat solid tumors in children, and...
Can a Transplant Cure Aging? | Catherine Baucom MD PhD
In this episode, Dr. Robert Lovekin talks with Dr. Catherine Baucom, chief medical officer of MitoSense, and veteran health expert Van about mitochondrial organelle transplantation—a novel therapy that injects healthy mitochondria from young donors into patients to repair damaged cells....
BREAKING: Study of 15,000 Nursing Homes Finds Death Risk Lasted Far Longer in the COVID-Vaccinated Than in the Unvaccinated After...
In this episode of Focal Points, host Nick interviews Dr. Nathaniel Mead, a McCullough Foundation scholar, about a new study of 15,000 U.S. nursing homes that examined mortality risk after COVID‑19 infection among vaccinated versus unvaccinated residents. The analysis of...
The Psychedelic Revolution
The episode explores the emerging field of psychedelic therapy, highlighting its potential to treat treatment‑resistant mental health conditions with a few supervised dosing sessions rather than daily medication. Guests Dr. Will Vanderveer and Keith Kurlander explain how the approach combines...
ONC’s Keane Says Government Will Strengthen TEFCA Onboarding to Address Provider Privacy Concerns
In this episode, ONC National Coordinator Tom Keen discusses recent organizational changes at ONC, the dual‑lane approach of TEFCA and CMS‑aligned networks, and how the government is strengthening TEFCA onboarding to address provider privacy concerns. He explains that ONC will...
Inside the RPA's Leadership Development Program
In this episode Tim Fitzpatrick chats with three early‑career nephrologists—Kinjal Shastri, Amandeep (Aman) Raman, and Raman Benaktar—about their recent participation in the Renal Physicians Association’s Leadership Development Program. The fellows explain that the year‑long fellowship pairs them with senior mentors,...
When Medical Inquiry and Empiricism Stopped
In this episode, Dr. Peter McCullough—a board‑certified internist, cardiologist, epidemiologist, and former chief academic officer at Ascension Health— discusses his career, his outspoken criticism of the COVID‑19 response, and his concerns about how science has been weaponized as institutional authority. He...
Dr Steven Phillipson and Sean: 'Sarnos' And Sean's Story (#533)
In this episode, clinical psychologist Dr. Steven Phillipson and his patient Sean discuss Sean’s experience with OCD, focusing on the concept of "Sarnos"—psychosomatic symptoms that arise from obsessive worries. Dr. Phillipson explains how exposure and response prevention (ERP) therapy, the...
Autism Affects 1 in 31: One Doctor’s Search for Answers
Dr. Elizabeth Mumper, a pediatrician with 46 years of experience, discusses the dramatic rise in autism prevalence from 1 in 5,000 to 1 in 31, arguing that environmental factors must be involved. She highlights that autism is no longer solely...
Drugs From a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge
In this episode of Touching Base, the GEN editors discuss how AI agents are accelerating scientific discovery, highlighting startups like Latent Labs that can design therapeutic antibodies from a simple text prompt and LabOS, an extended‑reality platform that integrates AI,...
Penn State Health’s DeFlitch & Hijjawi Say Past Lessons Can Help Guide Today’s AI Implementations
In this episode, Penn State Health’s Chief Medical Information Officer Dr. Chris DeFlich and Associate CMIO Dr. Shadi Hijawi discuss how past experiences with electronic health record (EHR) implementation can inform today’s rapid rollout of artificial intelligence (AI) tools in...
EP506: How Other Employers, Shareholders, and Clinics Are Using Price Transparency Data—And It's an Arms Race, With Jerry DiMaso
In this episode, Stacey Richter talks with Jerry DeMasso, CEO of Payerset, about how price‑transparency data is reshaping the healthcare market for self‑insured employers, plan sponsors, and clinical organizations. DeMasso explains three key insights employers can gain: benchmarking against competitors,...
Can You Exercise TOO Much With Rheumatoid Arthritis?
In this episode the host challenges the long‑standing rheumatology belief that people with rheumatoid arthritis (RA) must only engage in gentle exercise. By featuring ultra‑runner Natalie Tao—who completed a 700‑km ultramarathon despite having RA—the show illustrates how, with proper progression,...
#1 Neurologists: What You Can Do to Prevent Alzheimer's & Dementia
In this episode, Mel Robbins talks with neurologists Dr. Aisha Shirzai and Dr. Dean Shirzai about how lifestyle choices can dramatically reduce the risk of Alzheimer’s disease and other dementias. They explain that brain health is shaped by daily habits—not...
Interview with a Concerned, Australian Midwife.
In this candid interview, an anonymous Australian midwife with 27 years of experience describes a disturbing rise in postpartum hemorrhage cases since mid‑2023, noting massive blood loss, clots the size of tennis balls, and frequent emergency surgeries. She links the...
The Company Helping Paralyzed People Move And Thrive Again - EP 64 Dave Marver
In this episode, Dave Marver, CEO of Onward, explains how the company’s spinal cord stimulation platform, ArcIM, combined with a minimally invasive epidural brain‑computer interface (BCI), can translate a patient’s movement intentions into real‑time leg stimulation, enabling paralyzed individuals to...
Transforming the Healthcare Supply Chain: The Real Challenges We’re Facing (1 of 3)
In this episode, host Dave Kreisler talks with AI strategist and cybersecurity veteran Sagar Panja about the rapid shift in AI adoption across businesses and the cultural, data, and security challenges that accompany it. Panja emphasizes that successful AI implementation...
DDW Highlights: 7 April 2026
In this episode, Bruno Quinney highlights several breakthrough developments in drug discovery: the FDA’s accelerated approval of Avlaya, the first brain‑penetrant biologic for Hunter syndrome; Eli Lilly’s $2 billion acquisition of Centessa Pharmaceuticals to expand its orexin‑based sleep‑wake therapies; Mount Sinai’s AI‑powered...
Decentralized Trials That Scale Globally Without Compliance Risks - with Emma Vitalini of Amgen
In this episode, Emma Vitalini, Head of Global Digital Health Technology Innovation at Amgen, discusses how AI and decentralized trial technologies are transforming patient recruitment, screening, and global trial accessibility. She explains that AI can rapidly parse unstructured genomic and...
209. Will Trump's Pharmaceutical Tariffs Lower Prices and Secure Supply Chains?
In this episode, host Chad Bowne and guest Tom Boyke dissect the Trump administration’s new pharmaceutical tariffs and the U.S.-U.K. pricing arrangement, explaining how they aim to address two distinct challenges: low‑margin generic drug shortages tied to China and India,...
The Hart Of It All with Teri Hart
In the inaugural episode of "The Heart of It All," host Terri Hart shares her personal journey transitioning from caring for her father to supporting her mother, highlighting the emotional rollercoaster of caregiving. She discusses the challenges of shifting family...
GLP Podcast: Overdose Crisis—Illicit Opioids Spread Like Drug-Resistant Bacteria?
In this episode of the Facts and Fallacies podcast, hosts Cameron English and Dr. Liza Lockwood dissect the rapid evolution of illicit opioids, likening it to microbial drug resistance. They explain how prohibition drives black‑market producers to splice ever‑more potent...
Dr Sorcha O'Connor: The PsilOCD Study Investigating Low-Dose Psilocybin for OCD (#532)
In this episode, host Stuart Ralph talks with Dr. Saoirse O'Connor, a neuroscientist who led the PsilOCD study—the first controlled European trial of low‑dose psilocybin for obsessive‑compulsive disorder. The conversation covers the science of psilocybin, the study design (a 10 mg...
260: Dr. Michelle Jorgensen, Pioneer in Holistic Dentistry: Your Dentist Might Know Your Sleep Problem
In this episode, Dr. Michelle Jorgensen, a holistic dentist, explains how oral health—particularly mercury‑containing fillings, hidden infections, and airway obstruction—can drive inflammation and compromise sleep quality, leading to issues like bruxism and sleep apnea. She shares her personal journey from...
Food As Medicine: From Trend to Treatment W/ Spencer Pratt, Chief Growth Officer, NourishedRx
In this episode of CareTalk, John Driscoll speaks with Spencer Pratt, Chief Growth Officer of NourishedRx, about the company’s digital health platform that uses clinically‑guided food delivery, tele‑nutrition counseling, and digital coaching to treat diet‑related chronic diseases. Pratt explains how...
To Be or Not to Be, Reiley and His Vaccine Injury
The episode follows Reiley, who grew up on a massive cattle station in Western Australia, detailing his rugged, independent childhood and early work as an electrician before transitioning to strength‑and‑conditioning coaching. He recounts a harrowing COVID‑19 experience in Brazil in...
How Drug Discovery Is Tackling Global Health Challenges
In this DDW podcast episode, host Bruno Quinney discusses two recent DDW articles: one on the urgent need to combat antimicrobial resistance (AMR) with insights from Professor Janet Hemingway, and another on the rapid expansion of mRNA therapeutics. Hemingway highlights...
Corewell Health’s Jarve Says Population Health Data Challenges Demand Internal Builds
In this episode, Dr. Bob Jarvie, Associate CMIO and Medical Director for Population Health Analytics at Corewell Health, explains why the health system built its own internal population health data platform instead of relying on external vendors. He highlights the...